Physician profile
James Cole
NPI 1033108931
$1,043.98
in general payments reported to CMS, 2019-2025
11 companies · $356 in 2025
The $356 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $39.04 · 2021: $131 · 2023: $144 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $180.14 | 2019-2025 | Idosetr |
| Alcon Vision LLC | $158.08 | 2019-2021 | |
| Rxsight INC | $131.12 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Ocular Therapeutix, INC. | $130.03 | 2023 | Dextenza |
| Nestle Healthcare Nutrition INC. | $119.06 | 2021 | |
| Lensar, INC. | $114.10 | 2025 | Lensar Laser System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $113.25 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $39.04 | 2020 | |
| Novartis Pharmaceuticals Corporation | $25.08 | 2019 | |
| Sight Sciences, INC. | $19.84 | 2025 | Omni Surgical System |
| Oyster Point Pharma, INC. | $14.24 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.